Drug Type Small molecule drug |
Synonyms Altriabak, Ketotifen, Zabak + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Molecular FormulaC19H19NOS |
InChIKeyZCVMWBYGMWKGHF-UHFFFAOYSA-N |
CAS Registry34580-13-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 3 | Egypt | 09 Nov 2022 | |
Peripheral Nervous System Diseases | Phase 3 | Egypt | 09 Nov 2022 | |
Seasonal allergic conjunctivitis | Phase 2 | France | 01 Apr 2011 |
Phase 2 | 143 | Etafilcon A+Ketotifen (Etafilcon A With Ketotifen) | pqkjnssxss(wenzfyxkdc) = qclcyadqqd rkdshgbjqw (stpdswdxit, 0.0702) View more | - | 16 Mar 2021 | ||
Etafilcon A (Etafilcon A) | pqkjnssxss(wenzfyxkdc) = mwogpvlaof rkdshgbjqw (stpdswdxit, 0.0809) View more |